Brinker Capital Investments’s 10x Genomics TXG Stock Holding History

Brinker Capital Investments’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,636	Closed	-$158K	–	2126
2025 Q2	$158K	Buy	+13,636	New	+$124K	﹤0.01%	1923
2022 Q3	–	Sell	-9,262	Closed	-$419K	–	1393
2022 Q2	$419K	Buy	+9,262	New	+$481K	0.01%	1041
2021 Q4	–	Sell	-1,740	Closed	-$341K	–	1438
2021 Q3	$341K	Hold	1,740	–	–	0.01%	1097
2021 Q2	$341K	Buy	+1,740	New	+$315K	﹤0.01%	1151
2021 Q1	–	Sell	-1,914	Closed	-$271K	–	1265
2020 Q4	$271K	Buy	+1,914	New	+$278K	﹤0.01%	947

Other funds holding TXG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brinker Capital Investments's TXG Position: Q3 2025 in Review

Brinker Capital Investments sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 13,636 shares — an estimated $158K sold.

Brinker Capital Investments first reported a position in TXG in Q4 2020 and held it in 5 quarters. The position peaked at $419K in Q2 2022. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

Brinker Capital Investments reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
Brinker Capital Investments sold 13,636 10x Genomics shares in Q3 2025, an estimated $158K.
Brinker Capital Investments first reported a position in 10x Genomics in Q4 2020 and held it in 5 quarters.
Brinker Capital Investments's 10x Genomics position peaked at $419K in Q2 2022.
317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on Brinker Capital Investments's 13F filing for Q3 2025, filed 12 Nov 2025.